Outset Medical, Inc.
OM
$0.5781
$0.02514.54%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -3.41% | -5.59% | -24.01% | -15.83% | -4.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.41% | -5.59% | -24.01% | -15.83% | -4.69% |
| Cost of Revenue | -19.96% | -18.78% | -37.87% | -26.21% | -15.22% |
| Gross Profit | 44.45% | 37.21% | 26.99% | 27.80% | 48.70% |
| SG&A Expenses | -29.22% | -30.15% | -15.06% | -10.04% | -8.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.94% | -30.75% | -26.87% | -15.43% | -9.05% |
| Operating Income | 53.17% | 47.55% | 29.24% | 15.12% | 12.56% |
| Income Before Tax | 33.38% | 39.78% | 21.88% | 9.13% | 6.99% |
| Income Tax Expenses | -103.57% | 111.63% | 13.53% | -15.63% | 75.00% |
| Earnings from Continuing Operations | 33.58% | 39.50% | 21.78% | 9.16% | 6.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.58% | 39.50% | 21.78% | 9.16% | 6.86% |
| EBIT | 53.17% | 47.55% | 29.24% | 15.12% | 12.56% |
| EBITDA | 55.36% | 48.97% | 30.19% | 15.79% | 13.44% |
| EPS Basic | 36.71% | 40.20% | 26.19% | 12.95% | 10.34% |
| Normalized Basic EPS | 46.78% | 40.49% | 26.31% | 12.91% | 13.50% |
| EPS Diluted | 36.71% | 40.20% | 26.19% | 12.95% | 10.34% |
| Normalized Diluted EPS | 46.78% | 40.49% | 26.31% | 12.91% | 13.50% |
| Average Basic Shares Outstanding | 4.95% | 1.18% | 5.98% | 4.34% | 3.88% |
| Average Diluted Shares Outstanding | 4.95% | 1.18% | 5.98% | 4.34% | 3.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
